Concord Medical Services Holdings Ltd（CCM）股票分析

AI 分析 of Concord Medical Services Holdings Ltd (CCM)

买入

Concord Medical Services Holdings Ltd is a good buy right now due to its recent positive price momentum and improving financial metrics. The stock has increased by 3.92% over the last five days and has a forward P/E of 11.30, suggesting it may be undervalued compared to its earnings potential. Additionally, the gross margin has improved to 11.58%, indicating better operational efficiency. However, the main risk is the significant net loss of 32.8 million CNY in Q3 2025, which could impact future performance.

分析师评级（1）

卖出

0 买入

0 持有

1 卖出

当前: 3.71

最低

—

平均

—

最高

—

查看全部评级

估值指标

Concord Medical Services Holdings Ltd（CCM）当前预期市盈率为 11.30，5 年平均预期市盈率为 -31.33。

预期市盈率

高估

5 年均值 P/E

-31.33

当前P/E

11.30

高估

-7.56

低估

-55.11

预期 EV/EBITDA

低估

5 年均值 EV/EBITDA

58.46

当前EV/EBITDA

0.00

高估

98.90

低估

18.03

预期市销率

低估

5 年均值 P/S

1.04

当前P/S

0.00

高估

1.59

低估

0.48

Alphio AI 对 CCM 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重（25 / 50 / 25），不构成保证。

乐

乐观

乐观 · 25%CCM

$5.00

情景价格

基

基准

基准 · 50%CCM

$4.82

情景价格

悲

悲观

悲观 · 25%CCM

$4.59

情景价格

CCM 常见问题 —— 由 Alphio AI 解答

Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The Company operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector (OFFICES AND CLINICS OF DOCTORS OF MEDICINE industry).

Concord Medical Services Holdings Ltd is a good buy right now due to its recent positive price momentum and improving financial metrics. The stock has increased by 3.92% over the last five days and has a forward P/E of 11.30, suggesting it may be undervalued compared to its earnings potential. Additionally, the gross margin has improved to 11.58%, indicating better operational efficiency. However, the main risk is the significant net loss of 32.8 million CNY in Q3 2025, which could impact future performance.

1 analysts cover CCM: 0 rate it Buy, 0 Hold and 1 Sell.